| Family: | Invesco |
| Name: | Invesco S&P SmallCap Health Care ETF |
| Inception Date: | 7-Apr-2010 |
| Termination Date: | |
| Investment Objective: | The Invesco S&P SmallCap Health Care ETF (Fund) is based on the S&P SmallCap 600 Capped Health Care Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to measure the overall performance of common stocks in the health care sector. Included are healthcare companies principally engaged in the business of providing healthcare-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. |
| Prospectus | |
| Top 10 Holdings | ||
| GLAUKOS CORP USD 0.001 | GKOS | 5.0259% |
| PROTAGONIST THERAPEUTIC USD 0.00001 | PTGX | 4.9487% |
| TG THERAPEUTICS INC USD 0.001 | TGTX | 4.2770% |
| ALKERMES PLC USD 0.01 | ALKS | 3.9098% |
| LIGAND PHARMACEUTICALS IN USD 0.001 | LGND | 3.0505% |
| PTC THERAPEUTICS INC USD 0.001 | PTCT | 2.8731% |
| TELEFLEX INC USD 1.0 | TFX | 2.7894% |
| RADNET INC USD 0.0001 | RDNT | 2.7151% |
| MERIT MEDI COM NPV | MMSI | 2.6927% |
| LIQUIDIA CORPORATION USD 0.001 | LQDA | 2.6034% |
| Top 10 Holdings Weight: | 34.9% |
| Number of Holdings: | 72 |
| Shares Outstanding: | 3,470,000 |
| Total Net Assets: | 184,735,856 |
| NAV: | 53.26 |
| Net Expense Ratio: | 0.29% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Small Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
